Core Funding Programs

NOW ACCEPTING APPLICATIONS

Eligibility

Funding is open to researchers and clinicians worldwide at:

  • Academic medical centers and universities or nonprofits. Industry partnerships are encouraged.
  • Biotechnology companies. Existing companies and new startups are both eligible.
  • NOTE Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones (see Our Research Strategy for more information).

Drug Development RFP

Award Amount
Up to $600,000 based on stage and scope of research.
Payment structure will be negotiated and based on milestone achievements.

Award Duration
One year with potential for follow-on funding.

Program to Accelerate Clinical Trials (PACT) RFP

 

Award Amount
Up to $3,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment.

Average Duration
Multi-year

Allowable costs
Only direct costs are allowed. 

Neuroimaging and CSF Biomarker Development RFP

Award Amount
Up to $600,000 based on stage and scope of research.

Award Duration
One year with potential for follow-on funding.

Allowable costs
Only direct costs are allowed.


Prevention Pipeline RFP

 

Award Amount
Up to $3,000,000 for clinical trials based on stage and scope of research
For studies requiring additional support, co-funding from other funding agencies or investors is encouraged
Payment structure will be negotiated and based on milestone achievements and recruitment

Average Duration
Multi-year

Allowable costs
Only direct costs are allowed.


ADDF/NIH Funding and SBIR/STTR Bridge Funding Opportunities

 

Upcoming 2022 deadlines
Must be received by 5:00 pm ET on the deadline date.

Letter of Intent
February 4, 2022

Invited Full Proposal
April 8, 2022

Letter of Intent
May 20, 2022

Invited Full Proposal
July 22, 2022

Letter of Intent
September 30, 2022

Invited Full Proposal
December 2, 2022

WEBSITE

SFU Signature Sheet and Full Application are due to ORS 3 business days before the application deadline. 

Upcoming Deadlines

External
Internal
July 22, 2022July 22, 2022 Verified Date
July 19, 2022 Jul. 19, 2022 July 19, 2022 16:00:00 July 19, 2022 16:00:00 America/Vancouver Application Deadline: Core Funding Programs The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. NOTE: This funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. We have dedicated our funding to several key areas: - Translational research to develop new drugs and build preclinical evidence - IND-enabling studies and early-stage clinical trials for novel and repurposed drugs - Development and validation of plasma, CSF, neuroimaging and digital biomarkers - Epidemiological studies and comparative effectiveness research .
September 30, 2022September 30, 2022 Verified Date
16:00:00 16:00:00 America/Vancouver Application Deadline: Core Funding Programs The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. NOTE: This funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. We have dedicated our funding to several key areas: - Translational research to develop new drugs and build preclinical evidence - IND-enabling studies and early-stage clinical trials for novel and repurposed drugs - Development and validation of plasma, CSF, neuroimaging and digital biomarkers - Epidemiological studies and comparative effectiveness research .
December 02, 2022December 02, 2022 Verified Date
November 29, 2022 Nov. 29, 2022 November 29, 2022 16:00:00 November 29, 2022 16:00:00 America/Vancouver Application Deadline: Core Funding Programs The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. NOTE: This funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. We have dedicated our funding to several key areas: - Translational research to develop new drugs and build preclinical evidence - IND-enabling studies and early-stage clinical trials for novel and repurposed drugs - Development and validation of plasma, CSF, neuroimaging and digital biomarkers - Epidemiological studies and comparative effectiveness research .

x